)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Exosens
Exosens (EXENS) investor relations material
Exosens Q3 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 TU earnings summary27 Oct, 2026
Executive summary
9M 2026 revenue rose 18.0% to €386.9m, including 14.4% LFL growth; Q3 growth accelerated to 23.5%, including 20.5% LFL, on strong demand and faster capacity ramp-up.
Faster-than-expected European production ramp-up and continued commercial momentum support the confirmed upgraded 2026 outlook.
Financial highlights
9M revenue increased €59.1m YoY; acquisitions contributed alongside 14.4% LFL growth.
Adjusted gross margin rose 16.1% to €194.9m; the margin rate declined 85 bps YoY to 50.4%.
Outlook and guidance
FY 2026 revenue guidance is €558m–€570m; adjusted EBITDA guidance is €186m–€192m.
At guidance midpoints, 2026 implies ~20% revenue growth and ~25% adjusted EBITDA growth vs. 2025, with further profitability improvement.
2027 guidance is scheduled with FY 2026 results on 22 February 2027.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Exosens
- H1 2026 revenue up 15.3% with record margins and upgraded outlook despite brand impairment.EXENS
Q2 2026 - Strong growth, robust cash flow, and a €0.30 dividend highlight a record year and ambitious outlook.EXENSAGM 2026
- Q1 2026 revenue up 19.7%, fueled by defense demand and digital imaging, outlook reaffirmed.EXENSQ1 2026
- Record revenue and margin growth in 2025, with robust outlook and strong Defense momentum.EXENSQ4 2025
- Strong 9M 2025 growth with 23.2% higher revenue, margin gains, and robust defense demand.EXENSQ3 2025
- H1 2025 revenue up 20.1%, net profit surged to €27.9m, driven by Defense and acquisitions.EXENSQ2 2025
- Record growth, robust margins, and strategic expansion define Exosens' 2024 AGM.EXENSAGM 2025
- Q1 2025 revenue up 21.1%, driven by Defense demand and Amplification growth.EXENSQ1 2025
- FY 2024 revenue up 35% and net profit up 67%, with strong outlook for 2025.EXENSQ4 2024
Next Exosens earnings date
Q4 202622 Feb, 2027
Exosens
Next Exosens earnings date
Q4 202622 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Exosens specializes in the development, manufacture, and sale of electro-optical technologies, including amplification, detection, and imaging systems. The company offers a wide range of products such as image intensifier tubes, infrared cameras, x-ray components, gamma and neutron detectors, and methane airborne detection solutions. These technologies are utilized across various sectors, including scientific applications, defense, and industrial monitoring. The company is headquartered in Villeurbanne, Auvergne-Rhône-Alpes, France, and its shares are listed on the Euronext Paris.